CILIATECH is a medtech company specialized in ophthalmology, developing a new class of implant to address the increasing need to treat glaucoma durably with a novel design. Founded in 2017 by ophthalmic surgeon and inventor Dr. Philippe Sourdille and Olivier Benoit, a veteran engineer and biotech entrepreneur, CILIATECH developed the CID (Cilio-scleral Inter-positioning Device) groundbreaking concept ‘CID’ is the first implant in the industry to reduce IntraOcular Pressure (IOP) without needing to access the anterior chamber or create a subconjunctival filtration bleb. The device is implanted as a standalone procedure and in the latest trial has demonstrated efficacy in IOP lowering in both open angle glaucoma (POAG) and in narrow angle glaucoma - the latter is a real industry first. Implantation can be combined with cataract removal too. The company is located near Annecy, France - a beautiful region in the Western Alps which has been described as ‘the Alpine Venice’ www.cilia.tech
Lien externe pour CILIATECH - Glaucoma Innovators
178, Route de Cran-Gevrier
74650 Chavanod, Auvergne-Rhône-Alpes, FR
CILIATECH - Glaucoma Innovators a republié ceci
CILIATECH - Glaucoma Innovators has appointed a world-class panel of glaucoma surgeons to its newly formed KOL advisory board! 🌍 Together, they're set to revolutionise #glaucoma treatment with the Intercil® Uveal Spacer. https://lnkd.in/eMmUgrP8 #eyenews #Glaucoma #EyeCare Andrew Tatham Verena Prokosch Priv. Doz. Dr. med. Karl Mercieca Gus Gazzard Karsten Klabe Leon Au
CILIATECH - Glaucoma Innovators a republié ceci
!!I’m hiring!! With first ever commercial launches of our novel glaucoma device - the Intercil® Uveal Spacer - targeted for 2025, I’m looking to hire a very small number of (commercial/sales) Surgical Glaucoma Trainers to join my new commercial team! The first of these hires will be in Germany and the UK. You will primarily be based in your home nation but with a remit for additional international travel to support first surgical cases in the OR in multiple countries. If you are interested in applying feel free to message me directly here on LinkedIn, visit our LinkedIn company chat, or visit our website company website We are kindly not looking to receive contact from recruiters at the current time. The Intercil® Uveal Spacer is currently not available for sale pending regulatory approvals
CILIATECH - Glaucoma Innovators a republié ceci
📢 Web-conférence [Santé visuelle, santé de l'oeil : un bien fragile] Une matinée organisée par Pharmaceutiques 📅 Mardi 3 décembre 2024 en distanciel ⏰ 9h00 - 12h00 👉 Pour vous inscrire, cliquez ici : https://lnkd.in/d9rgPcEU CILIATECH - Glaucoma Innovators, société de medtech spécialisée en ophtalmologie, développe une nouvelle classe d’implants pour répondre au besoin croissant de traitement durable et sans effet indésirable contre le glaucome. Cette maladie touche 80 millions de personnes par an dans le monde. Olivier BENOIT I Philippe Sourdille I Pierre SANCHEZ I Herve Requillart I Julie Wierzbicki I Edouard Massé I Frédérique RONTEIX I Rachida NAÏT #oeil #santévisuelle #ophtalmologie #glaucome #myopie #maladiesoculaires #associations #colloque #conférence #IA #vision #patients #soins #medtech
CILIATECH - Glaucoma Innovators a republié ceci
CILIATECH - Glaucoma Innovators has established a new key opinion leader (KOL) advisory board. The seven-member board will help bring the Intercil Uveal Spacer – the company’s new cilioscleral inter-positioning device (CID) for #glaucoma – to market. Read more 👉 https://ow.ly/CuqG50UeFUm
CILIATECH - Glaucoma Innovators a republié ceci
ANNOUNCEMENTS! After putting in many months of work into two more enormous projects, I’m thrilled that today we at Ciliatech officially launch our brand new company website! More importantly, this comes along with the massively exciting privilege of being able to announce the official formation of our newly formed scientific Key Opinion Leader (KOL) advisory board. I would like to personally thank every one of our KOL advisors - each of whom so very kindly received my request for them to join our board in an advisory capacity - all of you very graciously said ‘YES’ which is a privilege for myself personally, and for Ciliatech. The Link to our brand new company website is in the comments Leon Au Priv. Doz. Dr. med. Karl Mercieca Karsten Klabe Verena Prokosch Andrew Tatham Gus Gazzard Ziad Khoueir Olivier BENOIT Philippe Sourdille Stephanie C. Jones Lauranne rieger CILIATECH - Glaucoma Innovators
[ALA Client News] CILIATECH - Glaucoma Innovators appoints world-class panel of eye care specialists to newly created Key Opinon Leader advisory board 👥 ☑️ Ciliatech will leverage ophthalmic expertise of seven-member advisory board to bring to market Intercil® Uveal Spacer, a novel glaucoma implant offering unique benefits to eye surgeons and patients across the globe 🌎 👉https://lnkd.in/eqe9MNqT Olivier BENOIT Philippe Sourdille Sahil Syed Andrew Tatham Verena Prokosch Ziad Khoueir Gus Gazzard Leon Au Priv. Doz. Dr. med. Karl Mercieca Karsten Klabe #ophthalmology #glaucoma #medtech #innovation #eyecare #appointments
CILIATECH - Glaucoma Innovators are extremely proud of our very own Stephanie C. Jones who has been selected as an OWL: Advancing Diversity in Leadership Fellow for 2024! The OWL Fellows Program increases support and connection opportunities by pairing rising and established leaders in the ophthalmic space. These connections allow parties to grow, share experiences and impact careers. OWL’s vision is to promote and develop diverse leadership to advance ophthalmic innovation and patient care, and to to elevate underrepresented parties in the ophthalmic space. Thanks to OWL for its continued work! Congrats again and best of luck Stephanie!! Olivier BENOIT Philippe Sourdille Sahil Syed Lauranne rieger Carol Leslie
CILIATECH - Glaucoma Innovators are excited to be represented at the American Academy of Ophthalmology by key members of our senior leadership team Please reach out if you would like to set up a meeting with Olivier BENOIT and Stephanie C. Jones Philippe Sourdille Sahil Syed Lauranne rieger N.B. Ciliatech products are not currently available for sale pending regulatory approvals
CILIATECH - Glaucoma Innovators are excited to be presenting at the Eyeceletator meeting at American Academy of Ophthalmology in Chicago! Olivier BENOIT Philippe Sourdille Stephanie C. Jones Sahil Syed Lauranne rieger N.B. The Intercil® Uveal Spacer is currently not available for sale pending regulatory approval
[ALA Client News] CILIATECH - Glaucoma Innovators selected to showcase Intercil® Uveal Spacer, novel glaucoma surgical device, at Eyecelerator ☑️ Major event for advancing innovation in eye care gives Ciliatech first-time opportunity to show US ophthalmic audiences potential of treating open and narrow angle glaucoma in supraciliary space with a single device https://lnkd.in/erhfcXVB Olivier BENOIT Philippe Sourdille Sahil Syed #medtech #ophthalmology #glaucoma #innovation
'How one ophthalmologist’s multi-decade-long experience led to the invention of an innovative supraciliary device' Read the unique and fascinating backstory of how CILIATECH - Glaucoma Innovators inventor, co-founder and Medical Director Dr. Philippe Sourdille came to invent the Intercil® Uveal Spacer which we now hope to commercialise in 2025 Our thanks to The Ophthalmologist for featuring the article! https://lnkd.in/e-NREpAz Andre Mermoud Olivier BENOIT Sahil Syed Stephanie C. Jones Lauranne rieger Gwenaëlle Lompré Carol Leslie N.B. The Intercil® Uveal Spacer is currently not available for sale pending regulatory approvals
CILIATECH - Glaucoma Innovators a republié ceci
Was a privilege to meet up again and sit with the incredible Professor Gus Gazzard yesterday to have more super interesting conversations…. ….hoping to share more news regarding our discussions soon! Thank you Gus for always being so open and personally supportive throughout my time in glaucoma